These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 8996291)

  • 1. Coronary stent placement in patients with acute myocardial infarction: comparison of clinical and angiographic outcome after randomization to antiplatelet or anticoagulant therapy.
    Schömig A; Neumann FJ; Walter H; Schühlen H; Hadamitzky M; Zitzmann-Roth EM; Dirschinger J; Hausleiter J; Blasini R; Schmitt C; Alt E; Kastrati A
    J Am Coll Cardiol; 1997 Jan; 29(1):28-34. PubMed ID: 8996291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Major benefit from antiplatelet therapy for patients at high risk for adverse cardiac events after coronary Palmaz-Schatz stent placement: analysis of a prospective risk stratification protocol in the Intracoronary Stenting and Antithrombotic Regimen (ISAR) trial.
    Schühlen H; Hadamitzky M; Walter H; Ulm K; Schömig A
    Circulation; 1997 Apr; 95(8):2015-21. PubMed ID: 9133509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restenosis after coronary stent placement and randomization to a 4-week combined antiplatelet or anticoagulant therapy: six-month angiographic follow-up of the Intracoronary Stenting and Antithrombotic Regimen (ISAR) Trial.
    Kastrati A; Schühlen H; Hausleiter J; Walter H; Zitzmann-Roth E; Hadamitzky M; Elezi S; Ulm K; Dirschinger J; Neumann FJ; Schömig A
    Circulation; 1997 Jul; 96(2):462-7. PubMed ID: 9244213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sustained benefit over four years from an initial combined antiplatelet regimen after coronary stent placement in the ISAR trial. Intracoronary Stenting and Antithrombotic Regimen.
    Schühlen H; Kastrati A; Pache J; Dirschinger J; Schömig A
    Am J Cardiol; 2001 Feb; 87(4):397-400. PubMed ID: 11179521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents.
    Schömig A; Neumann FJ; Kastrati A; Schühlen H; Blasini R; Hadamitzky M; Walter H; Zitzmann-Roth EM; Richardt G; Alt E; Schmitt C; Ulm K
    N Engl J Med; 1996 Apr; 334(17):1084-9. PubMed ID: 8598866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High pressure assisted coronary stent implantation accomplished without intravascular ultrasound guidance and subsequent anticoagulation.
    Nakamura S; Hall P; Gaglione A; Tiecco F; Di Maggio M; Maiello L; Martini G; Colombo A
    J Am Coll Cardiol; 1997 Jan; 29(1):21-7. PubMed ID: 8996290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiplatelet is superior to anticoagulant treatment after coronary stenting: fewer coronary and other events within 30 days after stenting.
    Foussas S; Alexopoulos D; Stefanadis C; Olympios C; Voudris V; Hatzimiltiadis S; Sionis D; Vavouranakis E; Vrahatis A; Fakiolas C; Pissimisis E; Stefanidis A; Zairis M; Pavlides G; Vitakis S; Louridas G; Cokkinos D; Toutouzas P
    Angiology; 2000 Apr; 51(4):289-94. PubMed ID: 10778998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance.
    Colombo A; Hall P; Nakamura S; Almagor Y; Maiello L; Martini G; Gaglione A; Goldberg SL; Tobis JM
    Circulation; 1995 Mar; 91(6):1676-88. PubMed ID: 7882474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary stent implantation without coumadin in acute myocardial infarction.
    Saito S; Hosokawa FG; Kim K; Tanaka S; Miyake S
    J Am Coll Cardiol; 1996 Jul; 28(1):74-81. PubMed ID: 8752797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wiktor stent for treatment of chronic total coronary artery occlusions: short- and long-term clinical and angiographic results from a large multicenter experience.
    Anzuini A; Rosanio S; Legrand V; Tocchi M; Coppi R; Bonnier H; Sheiban I; Kulbertus HE; Chierchia SL
    J Am Coll Cardiol; 1998 Feb; 31(2):281-8. PubMed ID: 9462568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of coronary artery stents on mortality and nonfatal myocardial infarction: meta-analysis of randomized trials comparing a strategy of routine stenting with that of balloon angioplasty.
    Al Suwaidi J; Holmes DR; Salam AM; Lennon R; Berger PB
    Am Heart J; 2004 May; 147(5):815-22. PubMed ID: 15131536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized multicenter comparison of conventional anticoagulation versus antiplatelet therapy in unplanned and elective coronary stenting. The full anticoagulation versus aspirin and ticlopidine (fantastic) study.
    Bertrand ME; Legrand V; Boland J; Fleck E; Bonnier J; Emmanuelson H; Vrolix M; Missault L; Chierchia S; Casaccia M; Niccoli L; Oto A; White C; Webb-Peploe M; Van Belle E; McFadden EP
    Circulation; 1998 Oct; 98(16):1597-603. PubMed ID: 9778323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Single-center experience with the Palmaz-Schatz intracoronary stent: the immediate results and medium- and long-term follow-up].
    Galassi AR; Tamburino C; Grassi R; Monaco A; Russo G; Ierna SM; Calvi V; Giuffrida G
    Cardiologia; 1996 Nov; 41(11):1097-105. PubMed ID: 9064207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized comparison of cilostazol versus ticlopidine hydrochloride for antiplatelet therapy after coronary stent implantation for prevention of late restenosis.
    Kamishirado H; Inoue T; Mizoguchi K; Uchida T; Nakata T; Sakuma M; Takayanagi K; Morooka S
    Am Heart J; 2002 Aug; 144(2):303-8. PubMed ID: 12177649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of cilostazol versus ticlopidine therapy after stent implantation.
    Park SW; Lee CW; Kim HS; Lee HJ; Park HK; Hong MK; Kim JJ; Park SJ
    Am J Cardiol; 1999 Sep; 84(5):511-4. PubMed ID: 10482146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of cilostazol on angiographic restenosis after coronary stent placement.
    Park SW; Lee CW; Kim HS; Lee NH; Nah DY; Hong MK; Kim JJ; Park SJ
    Am J Cardiol; 2000 Sep; 86(5):499-503. PubMed ID: 11009265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of cilostazol versus ticlopidine in coronary artery stenting.
    Yoon Y; Shim WH; Lee DH; Pyun WB; Kim IJ; Jang Y; Cho SY
    Am J Cardiol; 1999 Dec; 84(12):1375-80. PubMed ID: 10606107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of two antiplatelet regimens (aspirin alone versus aspirin + ticlopidine or clopidogrel) after intracoronary implantation of a carbofilm-coated stent.
    Bartorelli AL; Tamburino C; Trabattoni D; Galassi A; Serdoz R; Sheiban I; Piovaccari G; Zimarino M; Benassi A; Di Mario C; Sangiorgio P; Chierchia S; Reimers B;
    Am J Cardiol; 2007 Apr; 99(8):1062-6. PubMed ID: 17437728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immediate and long-term clinical and angiographic results of the Wiktor stent in the treatment of chronic coronary occlusions].
    Anzuini A; Rosanio S; Legrand V; Tocchi M; Coppi R; Marazzi G; Vicedomini G; Pagnotta P; Montorfano M; Bonnier H; Sheiban I; Kulbertus HE; Chierchia SL
    G Ital Cardiol; 1997 Sep; 27(9):881-91. PubMed ID: 9378193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators.
    Leon MB; Baim DS; Popma JJ; Gordon PC; Cutlip DE; Ho KK; Giambartolomei A; Diver DJ; Lasorda DM; Williams DO; Pocock SJ; Kuntz RE
    N Engl J Med; 1998 Dec; 339(23):1665-71. PubMed ID: 9834303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.